参考文献/References:
[1]Hajibabaie F,Kouhpayeh S,Mirian M,et al.MicroRNAs as the actors in the atherosclerosis scenario[J].J Physiol Biochem,2020,76(1):1-12.[2]Vartak T,Kumaresan S,Brennan E.Decoding microRNA drivers in atherosclerosis[J].Biosci Rep,2022,42(7):BSR20212355.[3]Yurikova OY,Aisina DE,Niyazova RE,et al.The interaction of miRNA-5p and miRNA-3p with the mRNAs of orthologous genes[J].Mol Biol (Mosk),2019,53(4):692-704.[4]Chandrasekera D,Katare R.Exosomal microRNAs in diabetic heart disease[J].Cardiovasc Diabetol,2022,21(1):122.[5]Saliminejad K,Khorram Khorshid HR,et al.An overview of microRNAs: biology,functions,therapeutics,and analysis methods[J].J Cell Physiol,2019,234(5):5451-5465.[6]Li ML,Liu Q,Lei JY,et al.MiR-362-3p inhibits the proliferation and migration of vascular smooth muscle cells in atherosclerosis by targeting ADAMTS1[J].Biochem Biophys Res Commun,2017,493(1):270-276.[7]Yang N,Dong B,Song YQ,et al.Downregulation of miR-637 promotes vascular smooth muscle cell proliferation and migration via regulation of insulin-like growth factor-2[J].Cell Mol Biol Lett,2020,25:30.[8]Wang HJ,Wei Z,Li HL,et al.MiR-377-3p inhibits atherosclerosis-associated vascular smooth muscle cell proliferation and migration via targeting neuropilin2[J].Biosci Rep,2020,40(6):BSR20193425.[9]Ghasempour G,Mahabadi VP,Shabani M,et al.MiR-181b and miR-204 suppress the VSMC proliferation and migration by downregulation of HCK[J].Microvasc Res,2021,136:104172.[10]Ye D,Lou GH,Li AC,et al.MicroRNA-125a-mediated regulation of the mevalonate signaling pathway contributes to high glucose?induced proliferation and migration of vascular smooth muscle cells[J].Mol Med Rep,2020,22(1):165-174.[11]Feng SD,Gao L,Zhang DH,et al.MiR-93 regulates vascular smooth muscle cell proliferation,and neointimal formation through targeting Mfn2[J].Int J Biol Sci,2019,15(12):2615-2626.[12]Liu SY,Yang YY,Jiang SY,et al.MiR-378a-5p regulates proliferation and migration in vascular smooth muscle cell by targeting CDK1[J].Front Genet,2019,10:22.[13]Wang JY,Zhang CX,Li C,et al.MicroRNA-92a promotes vascular smooth muscle cell proliferation and migration through the ROCK/MLCK signalling pathway[J].J Cell Mol Med,2019,23(5):3696-3710.[14]Zhang C,Wang X.MiR-320a targeting RGS5 aggravates atherosclerosis by promoting migration and proliferation of ox-LDL-stimulated vascular smooth muscle cells[J].J Cardiovasc Pharmacol,2022,80(1):110-117.[15]Kang XL,Cao SM,Ji Z,et al.MiR-3646 promotes vascular inflammation and augments vascular smooth muscle cell proliferation and migration in progression of coronary artery disease by directly targeting RHOH[J].Int J Clin Exp Pathol,2018,11(12):5830-5839.[16]Sun B,Cao QT,Meng M,et al.MicroRNA-186-5p serves as a diagnostic biomarker in atherosclerosis and regulates vascular smooth muscle cell proliferation and migration[J].Cell Mol Biol Lett,2020,25:27.[17]Phadwal K,Feng D,Zhu DX,et al.Autophagy as a novel therapeutic target in vascular calcification[J].Pharmacol Ther,2020,206:107430.[18]Farina FM,Hall IF,Serio S,et al.MiR-128-3p is a novel regulator of vascular smooth muscle cell phenotypic switch and vascular diseases[J].Circ Res,2020,126(12):e120-e135.[19]Yan SR,Chen J,Zhang T,et al.Micro-RNA-338-3p promotes the development of atherosclerosis by targeting desmin and promoting proliferation[J].Mol Biotechnol,2021,63(9):840-848.[20]Yu TC,Wang T,Kuang SF,et al.A microRNA-17-5p/homeobox B13 axis participates in the phenotypic modulation of vascular smooth muscle cells[J].Mol Med Rep,2021,24(4):731.[21]常峥峥,林飞,赵晖,等.微小RNA-33a对平滑肌细胞表型转化的调控机制研究[J].中国循环杂志,2021,36(12):1221-1228.[22]Zhuang XJ,Gao F,Shi L,et al.MicroRNA-146b-3p regulates the dysfunction of vascular smooth muscle cells via repressing phosphoinositide-3 kinase catalytic subunit gamma[J].Bioengineered,2021,12(1):2627-2638.[23]Chin DD,Poon C,Wang J,et al.MiR-145 micelles mitigate atherosclerosis by modulating vascular smooth muscle cell phenotype[J].Biomaterials,2021,273:120810.[24]Wang XQ,Li H,Zhang YT,et al.Suppression of miR-4463 promotes phenotypic switching in VSMCs treated with Ox-LDL[J].Cell Tissue Res,2021,383(3):1155-1165.[25]Hu M,Jia F,Huang WP,et al.Substrate stiffness differentially impacts autophagy of endothelial cells and smooth muscle cells[J].Bioact Mater,2021,6(5):1413-1422.[26]Cui RR,Ye SL,Zhong JY,et al.MicroRNA-494 inhibits apoptosis of murine vascular smooth muscle cells in vitro[J].Mol Med Rep,2019,19(5):4457-4467.[27]Luo Y,Li YM,Peng H,et al.MiR-140-5p regulates vascular smooth muscle cell viability,migration and apoptosis by targeting ROBO4 gene expression in atherosclerosis[J].Mol Med Rep,2021,23(3):213.[28]Wang L,Zhou JL,Guo F,et al.MicroRNA-665 regulates cell proliferation and apoptosis of vascular smooth muscle cells by targeting TGFBR1[J].Int Heart J,2021,62(2):371-380.[29]Bao Q,Jia H,A R,et al.MiR-210 inhibits hypoxia-induced apoptosis of smooth muscle cells via targeting MEF2C[J].Int J Clin Exp Pathol,2019,12(5):1846-1858.[30]Wang L,Wang ZB,Zhang R,et al.MiR-4787-5p regulates vascular smooth muscle cell apoptosis by targeting PKD1 and inhibiting the PI3K/Akt/FKHR pathway[J].J Cardiovasc Pharmacol,2021,78(2):288-296.[31]Wang WR,Chen LF,Shang CX,et al.MiR-145 inhibits the proliferation and migration of vascular smooth muscle cells by regulating autophagy[J].J Cell Mol Med,2020,24(12):6658-6669.[32]Qin Y,Zheng B,Yang GS,et al.Salvia miltiorrhiza-derived sal-miR-58 induces autophagy and attenuates inflammation in vascular smooth muscle cells[J].Mol Ther Nucleic Acids,2020,21:492-511.[33]Liang X,Hu MY,Yuan W,et al.MicroRNA-4487 regulates vascular smooth muscle cell proliferation,migration and apoptosis by targeting RAS p21 protein activator 1[J].Pathol Res Pract,2022,234:153903.[34]Grootaert MOJ,Moulis M,Roth L,et al.Vascular smooth muscle cell death,autophagy and senescence in atherosclerosis[J].Cardiovasc Res,2018,114(4):622-634.[35]Chen YL,Sheu JJ,Sun CK,et al.MicroRNA-214 modulates the senescence of vascular smooth muscle cells in carotid artery stenosis[J].Mol Med,2020,26(1):46.[36]Chen TB,Liang QY,Xu JL,et al.MiR-665 regulates vascular smooth muscle cell senescence by interacting with LncRNA GAS5/SDC1[J].Front Cell Dev Biol,2021,9:700006.[37]Tan P,Wang HQ,Zhan JK,et al.Rapamycin-induced miR-30a downregulation inhibits senescence of VSMCs by targeting Beclin1[J].Int J Mol Med,2019,43(3):1311-1320.[38]Durham AL,Speer MY,Scatena M,et al.Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness[J].Cardiovasc Res,2018,114(4):590-600.[39]He L,Xu JS,Bai YL,et al.MicroRNA-103a regulates the calcification of vascular smooth muscle cells by targeting runt-related transcription factor 2 in high phosphorus conditions[J].Exp Ther Med,2021,22(3):1036.[40]Han YC,Zhang JC,Huang S,et al.MicroRNA-223-3p inhibits vascular calcification and the osteogenic switch of vascular smooth muscle cells[J].J Biol Chem,2021,296:100483.[41]Cao JS,Chen L,Zhong XL,et al.miR32-5p promoted vascular smooth muscle cell calcification by upregulating TNFα in the microenvironment[J].BMC Immunol,2020,21(1):3.[42]Li Y,Sun W,Saaoud F,et al.MiR155 modulates vascular calcification by regulating Akt-FOXO3a signalling and apoptosis in vascular smooth muscle cells[J].J Cell Mol Med,2021,25(1):535-548.[43]Choe N,Shin S,Joung H,et al.The microRNA miR-134-5p induces calcium deposition by inhibiting histone deacetylase 5 in vascular smooth muscle cells[J].J Cell Mol Med,2020,24(18):10542-10550.[44]Zhang F,Li JX,Gu CX,et al.MiR-140-5p upregulation suppressed β-glycerophosphate-induced vascular smooth muscle cell calcification via targeting TLR4[J].Immunopharmacol Immunotoxicol,2022,44(3):295-305.[45]Wang J,Qian HL,Chen SY,et al.MiR-22 eluting cardiovascular stent based on a self-healable spongy coating inhibits in-stent restenosis[J].Bioact Mater,2021,6(12):4686-4696.[46]Izuhara M,Kuwabara Y,Saito N,et al.Prevention of neointimal formation using miRNA-126-containing nanoparticle-conjugated stents in a rabbit model[J].PLoS One,2017,12(3):e0172798.
相似文献/References:
[1]王立民,刘有旺,王恩波,等.以大黄素为声敏剂介导声动力疗法对小鼠
动脉粥样硬化治疗作用的研究[J].医学信息,2018,31(06):58.[doi:10.3969/j.issn.1006-1959.2018.06.019]
WANG Li-min,LIU You-wang,WANG En-bo,et al.Study on the Effect of Emodin on the Treatment of Atherosclerosis in Mice[J].Journal of Medical Information,2018,31(06):58.[doi:10.3969/j.issn.1006-1959.2018.06.019]
[2]汤海霞,班 涛.大黄素与心血管疾病的研究[J].医学信息,2022,35(11):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
TANG Hai-xia,BAN Tao.Research on Emodin and Cardiovascular Diseases[J].Journal of Medical Information,2022,35(06):19.[doi:10.3969/j.issn.1006-1959.2022.11.006]
[3]陈玉媛,易爱姣,谭齐鸣,等.中青年冠状动脉粥样硬化患者颈动脉硬化的超声特征[J].医学信息,2019,32(02):175.[doi:10.3969/j.issn.1006-1959.2019.02.054]
CHEN Yu-yuan,YI Ai-jiao,TAN Qi-ming,et al.Ultrasound Characteristics of Carotid Atherosclerosis in Young and Middle-aged Patients with Coronary Atherosclerosis[J].Journal of Medical Information,2019,32(06):175.[doi:10.3969/j.issn.1006-1959.2019.02.054]
[4]杨玉媛,刘有旺,李 腾,等.Th17细胞对动脉粥样硬化斑块易损性和斑块破裂的影响研究[J].医学信息,2018,31(18):53.[doi:10.3969/j.issn.1006-1959.2018.18.017]
YANG Yu-yuan,LIU You-wang,LI Teng,et al.Effect of Th17 Cells on Atherosclerotic Plaque Vulnerability and Plaque Rupture[J].Journal of Medical Information,2018,31(06):53.[doi:10.3969/j.issn.1006-1959.2018.18.017]
[5]薛 一,孔莫维,高 宇.脂蛋白相关磷脂酶A2与冠心病的研究[J].医学信息,2019,32(12):53.[doi:10.3969/j.issn.1006-1959.2019.12.017]
XUE Yi,KONG Mo-wei,GAO Yu.Research on Lipoprotein-associated Phospholipase A2 and Coronary Heart Disease[J].Journal of Medical Information,2019,32(06):53.[doi:10.3969/j.issn.1006-1959.2019.12.017]
[6]李 靖.非高密度脂蛋白胆固醇与心脑血管疾病的关系研究[J].医学信息,2022,35(12):100.[doi:10.3969/j.issn.1006-1959.2022.12.024]
LI Jing.Study on the Relationship Between Non-high Density Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Diseases[J].Journal of Medical Information,2022,35(06):100.[doi:10.3969/j.issn.1006-1959.2022.12.024]
[7]郝冬冬,高 宇.C肽与动脉粥样硬化的相关性研究[J].医学信息,2019,32(09):28.[doi:10.3969/j.issn.1006-1959.2019.09.010]
HAO Dong-dong,GAO Yu.Correlation between C-peptide and Atherosclerosis[J].Journal of Medical Information,2019,32(06):28.[doi:10.3969/j.issn.1006-1959.2019.09.010]
[8]严文文,陈 然,金 平,等.老年患者颅内动脉粥样硬化性狭窄的分布和危险因素研究[J].医学信息,2019,32(09):78.[doi:10.3969/j.issn.1006-1959.2019.09.025]
YAN Wen-wen,CHEN Ran,JIN Ping,et al.Distribution and Risk Factors of Intracranial Atherosclerotic Stenosis in Elderly Patients[J].Journal of Medical Information,2019,32(06):78.[doi:10.3969/j.issn.1006-1959.2019.09.025]
[9]李慧丹,赵文鸽,王学惠.Nox4在同型半胱氨酸介导的动脉粥样硬化中作用的研究[J].医学信息,2019,32(15):45.[doi:10.3969/j.issn.1006-1959.2019.15.015]
LI Hui-dan,ZHAO Wen-ge,WANG Xue-hui.Research on the Role of Nox4 in Homocysteine-mediated Atherosclerosis[J].Journal of Medical Information,2019,32(06):45.[doi:10.3969/j.issn.1006-1959.2019.15.015]
[10]罗婵娟.子宫内膜癌组织中miR-143的表达及与预后的相关性分析[J].医学信息,2022,35(15):75.[doi:10.3969/j.issn.1006-1959.2022.15.016]
LUO Chan-juan.Expression of miR-143 in Endometrial Carcinoma Tissues and its Correlation with Prognosis[J].Journal of Medical Information,2022,35(06):75.[doi:10.3969/j.issn.1006-1959.2022.15.016]